Cargando…
165. Biofire pneumonia panel use in severe pneumonia and antibiotic treatment in COVID-19 patients
BACKGROUND: Hospitalized COVID-19 patients with severe pneumonia are commonly treated for secondary bacterial pneumonia. The Biofire pneumonia panel, a rapid molecular diagnostic tool with 18 bacterial, 8 viral and 7 resistance gene targets, was made available to critical care and infectious disease...
Autores principales: | Stohs, Erica J, McElligott, Maureen, Creager, Hannah M, Fey, Paul D, Van Schooneveld, Trevor C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751928/ http://dx.doi.org/10.1093/ofid/ofac492.243 |
Ejemplares similares
-
Pneumonia panel results and antibiotic prescribing in COVID-19 patients in 2020 versus 2022
por: Hussain, Aysha, et al.
Publicado: (2023) -
166. Impact of Pneumonia Panel Implementation with Stewardship Support on Antibiotic De-escalation in the ICU
por: Schooneveld, Trevor C Van, et al.
Publicado: (2023) -
164. BioFire FilmArray Pneumonia Panel Implementation: Examining Appropriate Usage and Opportunities for Diagnostic Stewardship
por: Zelus, Casey S, et al.
Publicado: (2022) -
Implementation of a Rapid Multiplex Polymerase Chain Reaction Pneumonia Panel and Subsequent Antibiotic De-escalation
por: Miller, Molly M, et al.
Publicado: (2023) -
2002. Evaluation of the BioFire(®) Pneumonia Panel in ICU Patients With Suspected Ventilator-Associated Pneumonia
por: Iannello, Alexandra, et al.
Publicado: (2018)